<DOC>
	<DOC>NCT01672827</DOC>
	<brief_summary>To Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]flutemetamol Positron Emission Tomography (PET) Images.</brief_summary>
	<brief_title>Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Subject received a dose of Flutemetamol F 18 Injection ranging from approximately 185 MBq to approximately 370 MBq. The subject was classified as one of the following: 1. Endoflife subject who expired and underwent brain autopsy, with histochemical (HC) confirmation of brain amyloid status. 2. Subject with known/suspected normal pressure hydrocephalus (NPH) who underwent brain biopsy, with HC confirmation of brain amyloid status. 3. Elderly healthy volunteer (age ≥55). 4. Young healthy volunteer (age ≤40). 5. Subject with probable Alzheimer Disease (pAD). 6. Subject with amnestic Mild Cognitive Impairment (aMCI).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Alzheimer's Disease</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Positron Emission Tomography (PET)</keyword>
	<keyword>PET Images</keyword>
</DOC>